Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy
Jennifer Giandhari, Adriaan E Basson, Katherine Sutherland, et al.
AIDS Research and Human Retroviruses
|
October 11, 2012
HIV-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest Uganda, 2004-2010
Anne Kapaata, Frederick Lyagoba, Deogratius Ssemwanga, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
Marion Tisseraud, Sébastien Goutal, Thomas Bonasera, et al.
Open Forum Infectious Diseases
|
March 26, 2025
Efficacy and Safety Outcomes in Adults Initiating Dolutegravir/Lamivudine With High Viral Load in the GEMINI-1/-2 and STAT Trials
Charlotte-Paige Rolle, José R Arribas, Roberto Ortiz, et al.
The Journal of General Virology
|
March 1, 2015
Analysis of the history and spread of HIV-1 in Uganda using phylodynamics
Gonzalo Yebra, Manon Ragonnet-Cronin, Deogratius Ssemwanga, et al.
ACS Omega
|
October 14, 2024
Improved Automated Radiosynthesis of [<sup>18</sup>F]Dolutegravir: Toward Clinical Applications
Steve Huvelle, Antoine Pinon, Christine Coulon, et al.
Therapeutic Advances in Infectious Disease
|
March 27, 2025
Fostemsavir resistance in clinical context: a narrative review
Jonathan M Schapiro, Rolf Kaiser, Mark Krystal, et al.
Plos One
|
August 30, 2014
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study
Andrew Swale, Fabio Miyajima, Paul Roberts, et al.
AIDS Research and Human Retroviruses
|
May 9, 2015
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
Jonathan K Kayondo, Nicaise Ndembi, Chris M Parry, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1
Adele L McCormick, Chris M Parry, Anne Crombe, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy
Jennifer Giandhari, Adriaan E Basson, Katherine Sutherland, et al.
AIDS Research and Human Retroviruses
|
October 11, 2012
HIV-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest Uganda, 2004-2010
Anne Kapaata, Frederick Lyagoba, Deogratius Ssemwanga, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 28, 2022
Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
Marion Tisseraud, Sébastien Goutal, Thomas Bonasera, et al.
Open Forum Infectious Diseases
|
March 26, 2025
Efficacy and Safety Outcomes in Adults Initiating Dolutegravir/Lamivudine With High Viral Load in the GEMINI-1/-2 and STAT Trials
Charlotte-Paige Rolle, José R Arribas, Roberto Ortiz, et al.
The Journal of General Virology
|
March 1, 2015
Analysis of the history and spread of HIV-1 in Uganda using phylodynamics
Gonzalo Yebra, Manon Ragonnet-Cronin, Deogratius Ssemwanga, et al.
ACS Omega
|
October 14, 2024
Improved Automated Radiosynthesis of [<sup>18</sup>F]Dolutegravir: Toward Clinical Applications
Steve Huvelle, Antoine Pinon, Christine Coulon, et al.
Therapeutic Advances in Infectious Disease
|
March 27, 2025
Fostemsavir resistance in clinical context: a narrative review
Jonathan M Schapiro, Rolf Kaiser, Mark Krystal, et al.
Plos One
|
August 30, 2014
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study
Andrew Swale, Fabio Miyajima, Paul Roberts, et al.
AIDS Research and Human Retroviruses
|
May 9, 2015
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
Jonathan K Kayondo, Nicaise Ndembi, Chris M Parry, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1
Adele L McCormick, Chris M Parry, Anne Crombe, et al.
Page
of 4